9.92
+0.78(+8.53%)
Currency In USD
| Previous Close | 9.14 |
| Open | 9.25 |
| Day High | 10.05 |
| Day Low | 9.21 |
| 52-Week High | 12.73 |
| 52-Week Low | 4.02 |
| Volume | 1.57M |
| Average Volume | 1.14M |
| Market Cap | 529.24M |
| PE | 3.79 |
| EPS | 2.62 |
| Moving Average 50 Days | 8.13 |
| Moving Average 200 Days | 7.35 |
| Change | 0.78 |
If you invested $1000 in Emergent BioSolutions Inc. (EBS) 10 years ago, it would be worth $336.96 as of October 07, 2025 at a share price of $9.92. Whereas If you bought $1000 worth of Emergent BioSolutions Inc. (EBS) shares 5 years ago, it would be worth $91.24 as of October 07, 2025 at a share price of $9.92.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Emergent BioSolutions Recognizes Several Important Observances to Help Save Lives from Opioid Poisoning and Encourages Preparedness with Life-Saving Naloxone
GlobeNewswire Inc.
Sep 24, 2025 8:05 PM GMT
GAITHERSBURG, Md., Sept. 24, 2025 (GLOBE NEWSWIRE) -- In recognition of several observances in September meant to keep the national opioid poisoning epidemic front and center, Emergent BioSolutions Inc. (NYSE: EBS) today recommitted to its leadersh
Emergent BioSolutions Secures $29 Million in MCM Product Orders from International Government Partner
GlobeNewswire Inc.
Sep 19, 2025 12:34 PM GMT
GAITHERSBURG, Md., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has secured new purchase orders from an international government partner for a multi-product supply agreement valued at $29 million (USD
Emergent BioSolutions Secures $17 Million Contract Modification for Oral Suspension TEMBEXA® (brincidofovir), a Smallpox Antiviral, and Strengthens Overall U.S. Supply Chain
GlobeNewswire Inc.
Sep 15, 2025 12:35 PM GMT
GAITHERSBURG, Md., Sept. 15, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received a $17 million contract modification from the Biomedical Advanced Research and Development Authority (BARDA), part of the Ad